Pierre Hirsch

3.3k citations
70 papers · 2.4k · 3 hit papers · h-index 23

Impact in

  • Hematology top 1%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 2%
    • Vascular Anomalies and Treatments
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 34
    • Chronic Myeloid Leukemia Treatments 13
    • Multiple Myeloma Research and Treatments 5
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 19
    • Vascular Anomalies and Treatments 5

Pierre Hirsch

62 papers receiving 2.3k citations

Pierre Hirsch's Hit Papers

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study 2022 · 168 citations
1680+3+6Years since publication200400600

Peers

Pierre Hirsch
Comparison fields: 5 of 79
  • Hematology 927
  • Genetics 580
  • Rheumatology 669
  • Cancer Research 402
  • Oncology 309
Replace Carmelo Gurnari with:
Carmelo Gurnari Italy
Elisabeth Oppliger Leibundgut Switzerland
Rajko Kušec Croatia
Fábio Pires de Souza Santos Brazil
Kimberly J. Hayes United States
Henrik Lilljebjörn Sweden
Roger J. Waltzman United States
Philippe Mineur Belgium
Pinkal M. Desai United States
Toshiko Motoji Japan
Pierre Hirsch relative to Carmelo Gurnari Italy Carmelo Gurnari's profile →
Citations per field
00.5×5×10×15×19×
Carmelo Gurnari · 1×
Citations per year

Countries citing papers authored by Pierre Hirsch

Since Specialization
Citations

This map shows the geographic impact of Pierre Hirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Hirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Hirsch more than expected).

Fields of papers citing papers by Pierre Hirsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Hirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Hirsch. The network helps show where Pierre Hirsch may publish in the future.

Co-authors

The 25 scholars most cited alongside Pierre Hirsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pierre Hirsch Line = papers co-authored together Pierre Hirsch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Hit paper breakdown →
2017694
2
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
Hit paper breakdown →
2021295
3
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
Hit paper breakdown →
2022168
4 201699
5 202269
6 201668
7 201165
8 200952
9 201448
10 202148
11 202046
12 201644
13 201243
14 201741
15 202035
16 201834
17 202132
18 202232
19 202029
20 201025

About Pierre Hirsch

Pierre Hirsch is a scholar working on Hematology, Genetics, Rheumatology, Cancer Research and Public Health, Environmental and Occupational Health, having authored 70 papers that have together received 2.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (34 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Otitis Media and Relapsing Polychondritis (13 papers), Chronic Myeloid Leukemia Treatments (13 papers), Acute Lymphoblastic Leukemia research (7 papers), Cancer Genomics and Diagnostics (5 papers), Vascular Anomalies and Treatments (5 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Hematology (927 citations), Genetics (580 citations), Rheumatology (669 citations), Cancer Research (402 citations) and Oncology (309 citations). Pierre Hirsch has collaborated with scholars based in France, United States and Armenia. Frequent co-authors include François Delhommeau, Ollivier Legrand, Christophe Marzac, Simona Lapusan, Ruoping Tang, Mohamad Mohty, Fanny Fava, Jean‐Pierre Marie, R. Tang and Arsène MEKINIAN. Their work appears in journals such as Blood, Haematologica, Leukemia, British Journal of Haematology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact